More and more, organizations charged with the health of our children and the public health of our communities are rethinking their support for marijuana prohibition.

AAP spoke up against the Schedule I classification of marijuana.

“A Schedule 1 listing means there’s no medical use or helpful indications, but we know that’s not true because there has been limited evidence showing [marijuana] may be helpful for certain conditions in adults,” says Seth Ammerman, a clinical professor in pediatrics at Stanford University and a member of the AAP national committee on substance abuse.

Dr. Ammerman was a co-author of the new policy statement. Currently, 23 states, plus the District of Columbia allow for the use of medical marijuana by qualified patients, but the lack of acknowledgement of marijuana’s potential medical benefits at the federal level has stalled research and prevented the development of medications that utilize the active ingredients in the marijuana plant.

Read full article at Drugpolicy.org